|
Based on its VitroGro® technology, Tissue Therapies is developing more effective treatments for acute and chronic wound healing applications including chronic skin ulcers and burns.
Tissue Therapies is also proceeding with the development of other commercial applications for VitroGro® and other technologies for the treatment of psoriasis, scar prevention and treatment and potential treatments for various cancers including those of the breast, colon and prostate.
|
The management and technical team of Tissue Therapies
are highly qualified and experienced.
 |
Interview with Dr. Steve Mercer CEO & Director of Tissue Therapies Ltd. |
|
Tissue Therapies current share price is available on
the ASX.
|
 |
|
